Dyne Therapeutics is expanding and strengthening its board, appointing Greene, while John Cox serves as CEO.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.